Bausch + Lomb Corporation (BLCO): Price and Financial Metrics

Bausch + Lomb Corporation (BLCO): $19.38

0.17 (-0.87%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

BLCO Price/Volume Stats

Current price $19.38 52-week high $21.69
Prev. close $19.55 52-week low $13.16
Day low $19.31 Volume 146,500
Day high $19.56 Avg. volume 563,125
50-day MA $19.57 Dividend yield N/A
200-day MA $16.57 Market Cap 6.83B

BLCO Stock Price Chart Interactive Chart >


Bausch + Lomb Corporation (BLCO) Company Bio


Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments and treatments for various eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases; and and contact lenses for therapeutic use. The Surgical segment provides medical device equipment, consumables, and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions. The company was founded in 1853 and is headquartered in Vaughan, Canada.


BLCO Latest News Stream


Event/Time News Detail
Loading, please wait...

BLCO Latest Social Stream


Loading social stream, please wait...

View Full BLCO Social Stream

BLCO Price Returns

1-mo -4.77%
3-mo 19.11%
6-mo 29.03%
1-year 27.00%
3-year N/A
5-year N/A
YTD 13.60%
2023 9.99%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!